TPG, a global investment firm, has acquired Kangji Medical, a leading Asian manufacturer of minimally invasive surgical instrument accessories (MISIA), for an undisclosed amount. This transaction marks a significant corporate acquisition for TPG in the medical technology sector, with Kangji Medical now operating as a privately held entity under TPG's ownership. The move clearly signifies TPG's full purchase of the company rather than a funding round.
Established in 2004, Kangji Medical has risen to become the No. 1 MISIA supplier in Asia. The company offers a comprehensive portfolio of laparoscopic and endoscopic surgical instruments, providing one-stop solutions for minimally invasive surgery across obstetrics, gynecology, general surgery, urology, and thoracic surgery specialties. Kangji Medical maintains a strong international presence, with sales active in over 60 countries throughout Europe, North America, Latin America, the Middle East, Africa, and Asia Pacific, supported by hundreds of strategic partners.
The acquisition is strategically driven by Kangji Medical's established market leadership, extensive product range, and significant global footprint within the medical device industry. TPG's investment aims to leverage Kangji's position as a high-technology enterprise specializing in the research and development, production, and sales of MISIA. This strategic alignment is expected to accelerate Kangji's growth trajectory and enhance its capabilities in product innovation and market penetration.
Looking forward, the combined entity is positioned to solidify its standing as a worldwide provider of complete solutions for endoscopic surgical instruments. The acquisition is anticipated to further Kangji Medical's mission to develop an internationally renowned brand in minimally invasive surgical products, ultimately contributing to advancements in human health through expanded access to high-quality surgical instruments.